Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Napp Pharmaceuticals Limited
Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0GW
Telephone: +44 (0)1223 424 444
Fax: +44 (0)1223 424 441
WWW: http://www.napp.co.uk
Medical Information Fax: +44 (0)1223 424 912

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 14/07/2011
PIL MXL capsules 30 mg, 60 mg, 90 mg, 120 mg, 150 mg, 200 mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/07/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/06/2011 and displayed until 14/07/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 24/05/2011 and displayed until 09/06/2011
Reasons for adding or updating:
  • Change to information about drinking alcohol
Updated on 02/07/2010 and displayed until 24/05/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 22/12/2009 and displayed until 02/07/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 25/09/2009 and displayed until 22/12/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 26/08/2009 and displayed until 25/09/2009
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 11/06/2008 and displayed until 26/08/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 28/09/2007 and displayed until 11/06/2008
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 08/01/2007 and displayed until 28/09/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to instructions about overdose
  • Change to side-effects
Updated on 18/12/2002 and displayed until 08/01/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 13/02/2002 and displayed until 18/12/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 24/10/2000 and displayed until 13/02/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  morphine sulphate